The Ensign Group, Inc. (ENSG) vs 10x Genomics, Inc. (TXG)
A side-by-side comparison of The Ensign Group, Inc. and 10x Genomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENSG
The Ensign Group, Inc.
$172.12HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
TXG
10x Genomics, Inc.
$80.28HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — ENSG vs TXG
growth of $100 · dividends reinvested · last 7yENSG +281.0% (+21.1%/yr)TXG +85.3% (+9.2%/yr)ENSG compounded faster over this window
ENSG TXG
ENSG vs TXG: by the numbers
- •TXG is the larger company ($10.19B vs $10.03B market cap).
- •ENSG is profitable (6.90% net margin) while TXG runs a net loss (-12.18%).
- •ENSG grew revenue faster over the past five years (17.08% vs 8.74% CAGR).
- •ENSG pays a dividend (0.15% yield), while TXG has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ENSG | TXG |
|---|---|---|
| P/E ratio | 26.98 | N/A |
| Forward P/E | 22.08 | N/A |
| PEG ratio | 1.95 | N/A |
| P/S ratio | 1.83 | 16.52 |
| P/B ratio | 4.11 | 12.35 |
| EV / EBITDA | 20.65 | N/A |
| FCF yield | 4.18% | 1.19% |
Profitability
| Metric | ENSG | TXG |
|---|---|---|
| Gross margin | 14.14% | 70.03% |
| Operating margin | 8.52% | -14.33% |
| Net margin | 6.90% | -12.18% |
| ROE | 15.51% | -9.10% |
| ROIC | 7.29% | -9.57% |
Dividends
| Metric | ENSG | TXG |
|---|---|---|
| Dividend yield | 0.15% | N/A |
| Payout ratio | 4.04% | N/A |
Growth (annualized)
| Metric | ENSG | TXG |
|---|---|---|
| Revenue CAGR (5Y) | 17.08% | 8.74% |
| EPS CAGR (5Y) | 13.47% | N/A |
| FCF CAGR (5Y) | 10.84% | N/A |
| Total return CAGR (5Y) | 18.33% | -7.24% |
Frequently asked
- Which has grown faster, ENSG or TXG?
- Over the past five years, ENSG grew revenue faster — ENSG at a 17.08% CAGR versus TXG at 8.74%.
- Does ENSG or TXG pay a bigger dividend?
- ENSG pays a dividend (0.15% yield), while TXG has no payments in the available dividend history.
- Is ENSG or TXG more profitable?
- ENSG runs the higher net margin — ENSG at 6.90% versus TXG at -12.18%.
- How have ENSG and TXG total returns compared?
- Over the past 5 years, ENSG delivered 18.33% and TXG delivered -7.24% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ensign P/E ratioEnsign dividend yieldEnsign ROE10x Genomics ROEEnsign operating margin10x Genomics operating marginEnsign revenue growth10x Genomics revenue growthEnsign free cash flow10x Genomics free cash flow
Ensign & 10x Genomics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.